14-76499975-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The ENST00000509242.5(ESRRB):​c.1409C>T​(p.Pro470Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000943 in 1,600,692 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00081 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00096 ( 6 hom. )

Consequence

ESRRB
ENST00000509242.5 missense

Scores

2
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 0.0320

Publications

5 publications found
Variant links:
Genes affected
ESRRB (HGNC:3473): (estrogen related receptor beta) This gene encodes a protein with similarity to the estrogen receptor. Its function is unknown; however, a similar protein in mouse plays an essential role in placental development. [provided by RefSeq, Jul 2008]
ESRRB Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 35
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0043939054).
BP6
Variant 14-76499975-C-T is Benign according to our data. Variant chr14-76499975-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 163424.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000808 (123/152272) while in subpopulation SAS AF = 0.00456 (22/4826). AF 95% confidence interval is 0.00309. There are 1 homozygotes in GnomAd4. There are 61 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ESRRBNM_001379180.1 linkc.*1517C>T 3_prime_UTR_variant Exon 7 of 7 ENST00000644823.1 NP_001366109.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ESRRBENST00000644823.1 linkc.*1517C>T 3_prime_UTR_variant Exon 7 of 7 NM_001379180.1 ENSP00000493776.1 A0A2R8Y491

Frequencies

GnomAD3 genomes
AF:
0.000808
AC:
123
AN:
152154
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00144
Gnomad ASJ
AF:
0.0104
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00455
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000426
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00132
AC:
295
AN:
223360
AF XY:
0.00152
show subpopulations
Gnomad AFR exome
AF:
0.0000732
Gnomad AMR exome
AF:
0.000480
Gnomad ASJ exome
AF:
0.0106
Gnomad EAS exome
AF:
0.000240
Gnomad FIN exome
AF:
0.0000490
Gnomad NFE exome
AF:
0.000495
Gnomad OTH exome
AF:
0.000708
GnomAD4 exome
AF:
0.000957
AC:
1386
AN:
1448420
Hom.:
6
Cov.:
31
AF XY:
0.00107
AC XY:
768
AN XY:
718748
show subpopulations
African (AFR)
AF:
0.000150
AC:
5
AN:
33308
American (AMR)
AF:
0.000306
AC:
13
AN:
42434
Ashkenazi Jewish (ASJ)
AF:
0.0113
AC:
291
AN:
25774
East Asian (EAS)
AF:
0.0000508
AC:
2
AN:
39348
South Asian (SAS)
AF:
0.00455
AC:
381
AN:
83738
European-Finnish (FIN)
AF:
0.0000570
AC:
3
AN:
52662
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5756
European-Non Finnish (NFE)
AF:
0.000531
AC:
587
AN:
1105332
Other (OTH)
AF:
0.00155
AC:
93
AN:
60068
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
87
174
262
349
436
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000808
AC:
123
AN:
152272
Hom.:
1
Cov.:
33
AF XY:
0.000819
AC XY:
61
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41540
American (AMR)
AF:
0.00144
AC:
22
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0104
AC:
36
AN:
3468
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5170
South Asian (SAS)
AF:
0.00456
AC:
22
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000426
AC:
29
AN:
68026
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000799
Hom.:
2
Bravo
AF:
0.000865
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000943
AC:
3
ExAC
AF:
0.00114
AC:
138
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:2
Apr 10, 2017
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 18, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Pro470Leu in exon 10 of ESRRB: This variant is not expected to have clinical s ignificance because it has been identified in 0.6% (62/10790) of South Asian chr omosomes, including 1 homozygote, by the Exome Aggregation Consortium (ExAC, htt p://exac.broadinstitute.org; dbSNP rs201726554). -

not provided Benign:2
Sep 28, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 12, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 35 Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

ESRRB-related disorder Benign:1
Dec 09, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
5.1
DANN
Uncertain
0.98
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.019
N
LIST_S2
Benign
0.43
.;T
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.0044
T;T
MetaSVM
Benign
-0.43
T
MutationAssessor
Benign
0.34
N;N
PhyloP100
0.032
PrimateAI
Benign
0.21
T
PROVEAN
Benign
-0.060
N;N
REVEL
Benign
0.13
Sift
Uncertain
0.0050
D;D
Sift4G
Benign
0.23
T;T
Vest4
0.067
MVP
0.36
MPC
0.39
ClinPred
0.013
T
GERP RS
0.43
gMVP
0.10
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201726554; hg19: chr14-76966318; API